Article
Selpercatinib May be an Effective NSCLC Treatment
Rating:
0.0
Views:
82
Likes:
1
Library:
1
Consistent efficacy was seen with selpercatinib in patients with RET fusion-positive non-small cell lung cancer, regardless of prior treatments.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value